AVEO Pharmaceuticals Book Value:
141.18M for Dec. 31, 2012AVEO Pharmaceuticals Historical Book Value Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 141.18M |
| Dec. 31, 2012 | 118.94M |
| Sept. 30, 2012 | 138.19M |
| June 30, 2012 | 165.83M |
| March 31, 2012 | 192.91M |
| Dec. 31, 2011 | 223.54M |
| Sept. 30, 2011 | 246.30M |
| June 30, 2011 | 267.96M |
| March 31, 2011 | 158.84M |
| Dec. 31, 2010 | 71.77M |
| Sept. 30, 2010 | 23.41M |
| June 30, 2010 | 40.81M |
| March 31, 2010 | 46.34M |
| Dec. 31, 2009 | -170.29M |
| Sept. 30, 2009 | -160.37M |
| Dec. 31, 2008 | -128.69M |
About Book Value of Equity
YCharts' book value of equity is the equivalent of total assets less total liabilities and preferred equity.
The book value of equity represents the equity of shareholders (from a balance sheet perspective) less the preferred stock.
Learn More
AVEO Book Value Benchmarks
| Companies | |
|---|---|
| Onyx Pharmaceuticals | 1.159B |
| Galena Biopharma | 27.76M |
| Sarepta Therapeutics | 123.68M |
AVEO Book Value Rankings
| Overall |
61st percentile 3044 of 8002 |
| Sector |
67th percentile 219 of 684 in Healthcare |
| Industry |
81st percentile 45 of 248 in Biotechnology |
AVEO Book Value Range, Past 5 Years
| Minimum | -170.29M | Dec 2009 |
| Maximum | 267.96M | Jun 2011 |
| Average | 86.04M |
AVEO News
Law Offices of Todd M. Garber Announces Investigation of AVEO Pharmaceuticals, Inc.
Business Wire May 20
Business Wire May 20
Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
Street Insider May 17
Street Insider May 17